BSE filing, NSE: ABBOTINDIA. Summary written from the filing by ALFA Finder's alert engine.
Abbott India Ltd: key numbers
- Share price
- ₹26,625.00
- Market cap
- ₹56,576 Cr
- Revenue (annual)
- ₹6,929 Cr
- Net profit (annual)
- ₹1,552 Cr
- P/E (TTM)
- 35.0×Sector 41.3×
- Promoter holding
- 74.99%+0.00% QoQ
- FII holding
- 0.40%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Abbott India Ltd
All →Abbott India Board Meeting Date
Abbott India intimated BSE that its Board will meet on 5 Nov 2026 to approve Q2/H1 FY27 unaudited results. No financial figures are disclosed in this advance notice.
Abbott India Other Announcement
Abbott India Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI LODR Regulations. The report details the equity distribution among various shareholder categories.
Abbott India Other Announcement
Abbott India submitted the quarterly certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, regarding dematerialization of securities.
Abbott India Management Change
Ms. Sangeeta Shetty has resigned as Company Secretary and Compliance Officer of Abbott India Limited, effective October 28, 2026.
Abbott India Annual General Meeting
Abbott India Ltd held its 82nd Annual General Meeting on August 13, 2026. Key business items, including dividend declaration and appointments, were discussed.
Abbott India Q1 FY27 Results: Net Profit ₹428.5 Cr, Up 17.1% YoY
Abbott India Ltd reported revenue from operations of ₹1,814 Cr (+4.3% YoY) and net profit of ₹428.5 Cr (+17.1% YoY) for Q1 FY27.
- Key figure
- Net profit ₹428.5 Cr · +17.1% YoY
Other business update announcements
All →Northern Arc Capital Business Update
Northern Arc's subsidiary reached a first close of over ₹400 Crore for its Diversified Debt Fund. The India Impact Fund matured with a 14.59% gross XIRR.
- Value
- ₹400.0 Cr
Cupid Business Update
Cupid Limited entered an exclusive long-term retail arrangement with V2 Retail, securing dedicated space across 425+ stores. Management targets about ₹400 crore incremental revenue within a year.
- Execution
- Long-term arrangement; nationwide product availability targeted by mid-December 2026; revenue expectation within 12 months
Ugro Capital Business Update
UGRO Capital released a social impact study showing 58% of borrowers saw revenue growth after loans. The study was independently conducted with Impactree.
MPS Business Update
MPS Limited's Chairman and CEO, Rahul Arora, participated in a media interaction with CNBC-TV18. The discussion covered Q2FY27 financial results, business performance, and growth outlook.
Exicom Tele-Systems Business Update
Exicom Tele-Systems is consolidating manufacturing by transitioning operations from its Gurugram facility to existing plants in Hyderabad and Solan. The transition aims to optimize infrastructure and is expected to finish by November 15, 2026.
- Execution
- November 15, 2026
Kwality Pharmaceuticals Business Update
Kwality Pharmaceuticals secured EU-GMP approval from Hungary for its Cephalosporin and Oncology facilities. This expands its EU-approved manufacturing footprint and positions it for global licensing opportunities.